SAN DIEGO, Sept. 19, 2011 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) (“TearLab” or the “Company”) announced that, today at the European Society of Cataract and Refractive Surgeons Annual Congress in Vienna, prominent LASIK surgeon, Dr. Eric Donnenfeld, presented data from a multi-site refractive surgery center study designed to determine how pre- and post-LASIK tear osmolarity levels relate to rates of Dry Eye Disease (“DED”) and DED symptoms, if differences exist in patients who are pre-treated with ocular lubricants, and if pre-operative tear osmolarity levels relate to visual acuity outcomes.
